NCT04499716

Brief Summary

Total knee arthroplasty (TKA) is one of the most common orthopedic surgical procedure and is associated with severe pain in the immediate postoperative period, thus limiting early recovery. Postoperative pain management requires multimodal analgesia, combining drugs and injection of a local anesthetic (LA). For optimal pain management, several peripheral nerve blocks should be associated. Thus, a recent study shows that the combination of IPACK, femoral triangle and obturator nerve blocks (ITO blocks) provides an effective pain control after TKA. The hypothesis of this study is that a quadruple nerve block combining femoral, sciatic, obturator and lateral femoral cutaneous nerve blocks (quadri-block) could improve analgesia after TKA. The main objective of this monocenter, prospective, randomized, open-label, controlled trial is to assess the effect of quadri-block on morphine consumption after TKA compared to ITO blocks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 5, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

December 8, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2021

Completed
Last Updated

June 7, 2021

Status Verified

July 1, 2020

Enrollment Period

5 months

First QC Date

July 31, 2020

Last Update Submit

June 4, 2021

Conditions

Keywords

Knee arthroplasty, Regional anesthesia, Ropivacaine, Postoperative analgesia, Pain management, Opioids

Outcome Measures

Primary Outcomes (1)

  • Postoperative analgesia, defined by the morphine consumption in the first 48 hours post-surgery.

    Total amount of oxynorm (mg) administered during the first 48 hours post-surgery.

    48 hours

Secondary Outcomes (6)

  • Postoperative pain: Verbal Rating Scale (VRS)

    48 hours

  • Oxynorm consumption in the first 24 hours post-surgery

    24 hours

  • Ability to walk

    48 hours

  • Quadricep mobilization

    48 hours

  • Foot elevator muscle mobilization

    48 hours

  • +1 more secondary outcomes

Study Arms (2)

Arm 1: ITO group

ACTIVE COMPARATOR

Arm 1: IPACK combined with femoral triangle and obturator nerve blocks

Procedure: IPACKProcedure: Femoral triangle blockProcedure: Obturator nerve block

Arm 2 : Quadri-block group

EXPERIMENTAL

Arm 2 : Femoral, sciatic, obturator and lateral femoral cutaneous nerve blocks

Procedure: Obturator nerve blockProcedure: Femoral nerve blockProcedure: Sciatic nerve blockProcedure: Lateral femoral cutaneous nerve block

Interventions

IPACKPROCEDURE

25 milliliters of ropivacaine 0.3% will be injected between popliteal artery and femur.

Arm 1: ITO group

25 milliliters of ropivacaine 0.3% will be injected on the lateral side of the femoral artery at the distal part of the femoral triangle.

Arm 1: ITO group

20 milliliters of ropivacaine 0.3% will be injected between the adductor magnus and adductor brevis muscles and between the adductor brevis muscle the pectineus.

Arm 1: ITO groupArm 2 : Quadri-block group

20 milliliters of ropivacaine 0.3% will be injected in supine position under the fascia iliaca lateral to the femoral artery.

Arm 2 : Quadri-block group

25 milliliters of ropivacaine 0.3% will be injected in prone position in the subgluteal space by lateral approach.

Arm 2 : Quadri-block group

5 milliliters of ropivacaine 0.3% will be injected laterally to the sartorius muscle.

Arm 2 : Quadri-block group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older,
  • Primary total knee arthroplasty
  • Consent for participation,
  • Affiliation to a social security system

You may not qualify if:

  • Preoperative morphine use
  • Chronic pain syndrome
  • Contraindication to any drugs used in the protocol (paracetamol, ketoprofen, oxynorm, propofol, ketamine, ropivacaine)
  • Valgus \> 9°
  • Pregnant or breastfeeding women
  • Patients under protection of the adults (guardianship, curators or safeguard of justice)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Médipôle Garonne

Toulouse, Haute-Garonne, 31036, France

Location

Related Publications (1)

  • Marty P, Chassery C, Rontes O, Vuillaume C, Basset B, Merouani M, Marquis C, De Lussy A, Ferre F, Naudin C, Joshi GP, Delbos A. Combined proximal or distal nerve blocks for postoperative analgesia after total knee arthroplasty: a randomised controlled trial. Br J Anaesth. 2022 Sep;129(3):427-434. doi: 10.1016/j.bja.2022.05.024. Epub 2022 Jun 28.

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2020

First Posted

August 5, 2020

Study Start

December 8, 2020

Primary Completion

May 7, 2021

Study Completion

May 7, 2021

Last Updated

June 7, 2021

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations